BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28656498)

  • 1. Biphasic malignant tumours of the abdominal cavity.
    Almond LM; Warfield AT; Desai A; Gourevitch D; Ford SJ
    Int J Clin Oncol; 2017 Aug; 22(4):635-640. PubMed ID: 28656498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
    Berton-Rigaud D; Devouassoux-Shisheboran M; Ledermann JA; Leitao MM; Powell MA; Poveda A; Beale P; Glasspool RM; Creutzberg CL; Harter P; Kim JW; Reed NS; Ray-Coquard I
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S55-60. PubMed ID: 25341582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?
    McCluggage WG
    J Clin Pathol; 2002 May; 55(5):321-5. PubMed ID: 11986333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcinosarcomas in female genital tracts: general review].
    Guy JB; Trone JC; Casteillo F; Forest F; Pacaut C; Moncharmont C; Espenel S; Vallard A; Langrand Escure J; Collard O; Peoc'h M; Magné N
    Bull Cancer; 2014; 101(7-8):760-4. PubMed ID: 25091658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine Carcinosarcomas - Diagnosis and Management.
    Denschlag D; Ulrich UA
    Oncol Res Treat; 2018; 41(11):675-679. PubMed ID: 30317231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of mixed Müllerian tumours.
    D'Angelo E; Prat J
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):705-18. PubMed ID: 21742560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma (malignant mixed müllerian [mesodermal] tumor) of the uterus and ovary. Correlation of clinical, pathologic, and immunohistochemical features in 29 cases.
    Costa MJ; Khan R; Judd R
    Arch Pathol Lab Med; 1991 Jun; 115(6):583-90. PubMed ID: 1710102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review literature on uterine carcinosarcoma.
    Singh R
    J Cancer Res Ther; 2014; 10(3):461-8. PubMed ID: 25313723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.
    Zhao S; Bellone S; Lopez S; Thakral D; Schwab C; English DP; Black J; Cocco E; Choi J; Zammataro L; Predolini F; Bonazzoli E; Bi M; Buza N; Hui P; Wong S; Abu-Khalaf M; Ravaggi A; Bignotti E; Bandiera E; Romani C; Todeschini P; Tassi R; Zanotti L; Odicino F; Pecorelli S; Donzelli C; Ardighieri L; Facchetti F; Falchetti M; Silasi DA; Ratner E; Azodi M; Schwartz PE; Mane S; Angioli R; Terranova C; Quick CM; Edraki B; Bilgüvar K; Lee M; Choi M; Stiegler AL; Boggon TJ; Schlessinger J; Lifton RP; Santin AD
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12238-12243. PubMed ID: 27791010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis by comparative genomic hybridization of epithelial and spindle cell components in sarcomatoid carcinoma and carcinosarcoma: histogenetic aspects.
    Torenbeek R; Hermsen MA; Meijer GA; Baak JP; Meijer CJ
    J Pathol; 1999 Nov; 189(3):338-43. PubMed ID: 10547594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
    Costa MJ; Guinee D
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas.
    Liu Y; Weber Z; San Lucas FA; Deshpande A; Jakubek YA; Sulaiman R; Fagerness M; Flier N; Sulaiman J; Davis CM; Fowler J; Starks D; Rojas-Espaillat L; Lazar AJ; Davies GE; Ehli EA; Scheet P
    Gynecol Oncol; 2018 Nov; 151(2):243-249. PubMed ID: 30194005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinosarcomas and Related Cancers: Tumors Caught in the Act of Epithelial-Mesenchymal Transition.
    Pang A; Carbini M; Moreira AL; Maki RG
    J Clin Oncol; 2018 Jan; 36(2):210-216. PubMed ID: 29220296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare uterine cancer: carcinosarcomas. Review from histology to treatment.
    Artioli G; Wabersich J; Ludwig K; Gardiman MP; Borgato L; Garbin F
    Crit Rev Oncol Hematol; 2015 Apr; 94(1):98-104. PubMed ID: 25468677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic and molecular features of uterine carcinosarcomas.
    Lopez-Garcia MA; Palacios J
    Semin Diagn Pathol; 2010 Nov; 27(4):274-86. PubMed ID: 21309261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinosarcoma of the uterus in advanced stage: a case report.
    Tasic L; Vasiljevic M; Prorocic M; Jurisic A; Dragojevic-Dikic S; Jankovic-Raznatovic S
    Eur J Gynaecol Oncol; 2013; 34(4):343-6. PubMed ID: 24020144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinosarcomas: tumors in transition?
    Somarelli JA; Boss MK; Epstein JI; Armstrong AJ; Garcia-Blanco MA
    Histol Histopathol; 2015 Jun; 30(6):673-87. PubMed ID: 25587806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinosarcomas--a retrospective analysis of 21 patients.
    Villena-Heinsen C; Diesing D; Fischer D; Griesinger G; Maas N; Diedrich K; Friedrich M
    Anticancer Res; 2006; 26(6C):4817-23. PubMed ID: 17214346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus: clinicoimmunohistochemical and histogenetic characteristics.
    Kedzia W; Pruski D; Iwaniec K; Przybylski M; Friebe Z; Rajpert-Kedzia H
    Folia Histochem Cytobiol; 2012; 50(4):513-8. PubMed ID: 23264213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphasic sarcomatoid carcinoma (carcinosarcoma) of the renal pelvis with heterologous chondrogenic differentiation.
    Vermeulen P; Hoekx L; Colpaert C; Wyndaele JJ; Van Marck E
    Virchows Arch; 2000 Aug; 437(2):194-7. PubMed ID: 10993282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.